Skip to main content
. 2014 May 15;9(5):e97808. doi: 10.1371/journal.pone.0097808

Table 1. Clinical Manifestations of Patients Carrying MYO7A Mutations.

USH01-III:1 USH01-III:2 USH02-II:1 USH03-II:1
O.D. O.S. O.D. O.S. O.D. O.S. O.D. O.S.
Genotype ( MYO7A )
Type of Mutation Biallelic Biallelic Homozygous Homozygous
Nucleotide Variation c.[1343+1G>A];[2837T>G] c.[1343+1G>A];[2837T>G] c.581_582del c.494C>T
Amino Acid Change p.[?];[Met946Arg] p.[?];[Met946Arg] p.Pro194Hisfs*13 p.Thr165Met
Novel or Recurrent Novel Novel Novel Recurrent
Frequency in Control Alleles 0/200 0/200 0/200 0/200
Accession Numbers in National Institutes of Health Sequence Read Archive
BioProject SRP040003 SRP040003 SRP040003 SRP040003
BioSamples SRS579268 SRS579270 SRS569215 SRS579266
Runs SRR1200449 SRR1200450 SRR1200411 SRR1200446
Age (years)/Sex 24/M 22/M 50/F 60/F
Walking Age 12-month 12-month 20-month 24-month
Onset Age for Hearing Impairments since born since born since born since born
Onset Age for Visual Defects 15-year-old 13-year-old 7-year-old 6-year-old
BCVAs (logMAR) 0.8 0.8 0.6 0.7 FC FC HM HM
IOP (mmHg) 14 13.8 13.2 14.5 14.5 18.5 17.5 16.5
Fundus Appearance
Macular Degeneration No No No No Yes Yes Yes Yes
Optic Disk Pale Pale Pale Pale Pale Pale Pale Pale
Artery Attenuation Yes Yes Yes Yes Yes Yes Yes Yes
Pigment Deposits Yes Yes Yes Yes Yes Yes Yes Yes
Visual Field TV TV TV TV NA NA NA NA
Electroretinography Diminished Diminished Diminished Diminished NA NA NA NA
Clinical Diagnosis USH type 2 USH type 2 USH type 1 USH type 1

Abbreviations: USH: usher syndrome; O.D.: right eye; O.S.: left eye; SD: splice site mutation; M: male; F: female; BCVA: best-corrected visual acuities; FC: finger count; HM: hand move; IOP: intraocular pressure; TV: tubular vision; NA: not available.